304 related articles for article (PubMed ID: 17456726)
1. Cellular mechanisms in sepsis.
Jean-Baptiste E
J Intensive Care Med; 2007; 22(2):63-72. PubMed ID: 17456726
[TBL] [Abstract][Full Text] [Related]
2. Sepsis and septic shock.
Zanetti G; Baumgartner JD; Glauser MP
Schweiz Med Wochenschr; 1997 Mar; 127(12):489-99. PubMed ID: 9106949
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic agents in the treatment of severe sepsis.
Iqbal O; Messmore H; Fareed J; Ahmad S; Hoppensteadt D; Hazar S; Tobu M; Aziz S; Wehrmacher W
Expert Opin Emerg Drugs; 2002 May; 7(1):111-39. PubMed ID: 15989540
[TBL] [Abstract][Full Text] [Related]
4. Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis.
Ayala A; Chaudry IH
Shock; 1996; 6 Suppl 1():S27-38. PubMed ID: 8828095
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology and treatment of gram-negative sepsis.
DiPiro JT
Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S6-10. PubMed ID: 2275478
[TBL] [Abstract][Full Text] [Related]
6. Compartmentalization of the inflammatory response in sepsis and SIRS.
Cavaillon JM; Annane D
J Endotoxin Res; 2006; 12(3):151-70. PubMed ID: 16719987
[TBL] [Abstract][Full Text] [Related]
7. Caspase-3 activation, Bcl-2 contents, and soluble FAS-ligand are not related to the inflammatory marker profile in patients with sepsis and septic shock.
Kriebel F; Wittemann S; Hsu HY; Joos T; Weiss M; Schneider EM
Ann N Y Acad Sci; 2006 Dec; 1090():168-76. PubMed ID: 17384259
[TBL] [Abstract][Full Text] [Related]
8. Effects of genomic polymorphisms on the course of sepsis: is there a concept for gene therapy?
Stüber F
J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S60-4. PubMed ID: 11251034
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor in septic shock.
Koltai M; Hosford D; Braquet PG
New Horiz; 1993 Feb; 1(1):87-95. PubMed ID: 7922397
[TBL] [Abstract][Full Text] [Related]
10. Cellular changes in association with defense mechanisms in intra-abdominal sepsis.
Pavlidis TE
Minerva Chir; 2003 Dec; 58(6):777-81. PubMed ID: 14663404
[TBL] [Abstract][Full Text] [Related]
11. Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin.
González-Navajas JM; Bellot P; Francés R; Zapater P; Muñoz C; García-Pagán JC; Pascual S; Pérez-Mateo M; Bosch J; Such J
J Hepatol; 2008 Jan; 48(1):61-7. PubMed ID: 17998145
[TBL] [Abstract][Full Text] [Related]
12. [Molecular biology and immunopathogenetic mechanisms of sepsis].
Průcha M
Cas Lek Cesk; 2009; 148(2):86-90. PubMed ID: 19637444
[TBL] [Abstract][Full Text] [Related]
13. Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade.
Giroir BP
Crit Care Med; 1993 May; 21(5):780-9. PubMed ID: 8482101
[TBL] [Abstract][Full Text] [Related]
14. Expression of monocyte human leukocyte antigen-DR in relation with sepsis severity and plasma mediators.
Payen D; Faivre V; Lukaszewicz AC; Villa F; Goldberg P
Minerva Anestesiol; 2009 Sep; 75(9):484-93. PubMed ID: 19644434
[TBL] [Abstract][Full Text] [Related]
15. Calcium: a regulator of the inflammatory response in endotoxemia and sepsis.
Hotchkiss RS; Karl IE
New Horiz; 1996 Feb; 4(1):58-71. PubMed ID: 8689276
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?
Sakr Y; Burgett U; Nacul FE; Reinhart K; Brunkhorst F
Crit Care Med; 2008 Jul; 36(7):2014-22. PubMed ID: 18552695
[TBL] [Abstract][Full Text] [Related]
17. Cytokines and sepsis: pathophysiology and therapy.
Shapiro L; Gelfand JA
New Horiz; 1993 Feb; 1(1):13-22. PubMed ID: 7922386
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional upregulation of inflammatory cytokines in human intestinal epithelial cells following Vibrio cholerae infection.
Bandyopadhaya A; Sarkar M; Chaudhuri K
FEBS J; 2007 Sep; 274(17):4631-42. PubMed ID: 17697117
[TBL] [Abstract][Full Text] [Related]
19. Immune modulation and sepsis.
Karzai W; Reinhart K
Int J Clin Pract; 1997 Jun; 51(4):232-7. PubMed ID: 9287265
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-kappaB.
Liu J; Zhao S; Tang J; Li Z; Zhong T; Liu Y; Chen D; Zhao M; Li Y; Gong X; Deng P; Wang JH; Jiang Y
FEBS J; 2009 Aug; 276(16):4598-606. PubMed ID: 19645720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
